Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Dewar

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|October 9, 2004
Managing metastatic bone painJohn A Dewar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Importance of long-term follow-up of women receiving adjuvant therapy for breast cancer in the communityColin McCowan, John A Dewar, Alastair M Thompson
Breast Cancer Research : BCR|September 20, 2005
A mathematical model for the effect of a false-negative sentinel node biopsy on breast cancer mortality: a tool for everyday useJayant S Vaidya, John A Dewar, Douglas C Brown, et al.
Journal of Clinical Nursing|December 21, 2007
A study to evaluate nurse-led on-treatment review for patients undergoing radiotherapy for head and neck cancerMary Wells, Peter T Donnan, Lena Sharp, et al.
BMJ (Clinical Research Ed.)|July 12, 2013
Beware using secular trends in deaths to judge effectiveness of breast screeningDavid H Brewster, Lesley A Bhatti, Catherine S Thomson, et al.
Mutagenesis|September 1, 2012
Topoisomerase IIα levels and G2 radiosensitivity in T-lymphocytes of women presenting with breast cancerPeter E Bryant, Andrew C Riches, Olga Shovman, et al.
Breast Cancer Research : BCR|November 10, 2010
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)Alastair M Thompson, Lee B Jordan, Philip Quinlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST StudyMatthew J Ellis, Antonio Llombart-Cussac, David Feltl, et al.
Breast (Edinburgh, Scotland)|February 3, 2012
A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyAndrew Fong, Jesmin Shafiq, Christobel Saunders, et al.
Breast Cancer Research and Treatment|June 10, 2011
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trialSirwan Hadad, Takayuki Iwamoto, Lee Jordan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|October 9, 2004
Managing metastatic bone painJohn A Dewar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Importance of long-term follow-up of women receiving adjuvant therapy for breast cancer in the communityColin McCowan, John A Dewar, Alastair M Thompson
Breast Cancer Research : BCR|September 20, 2005
A mathematical model for the effect of a false-negative sentinel node biopsy on breast cancer mortality: a tool for everyday useJayant S Vaidya, John A Dewar, Douglas C Brown, et al.
Journal of Clinical Nursing|December 21, 2007
A study to evaluate nurse-led on-treatment review for patients undergoing radiotherapy for head and neck cancerMary Wells, Peter T Donnan, Lena Sharp, et al.
BMJ (Clinical Research Ed.)|July 12, 2013
Beware using secular trends in deaths to judge effectiveness of breast screeningDavid H Brewster, Lesley A Bhatti, Catherine S Thomson, et al.
Mutagenesis|September 1, 2012
Topoisomerase IIα levels and G2 radiosensitivity in T-lymphocytes of women presenting with breast cancerPeter E Bryant, Andrew C Riches, Olga Shovman, et al.
Breast Cancer Research : BCR|November 10, 2010
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)Alastair M Thompson, Lee B Jordan, Philip Quinlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST StudyMatthew J Ellis, Antonio Llombart-Cussac, David Feltl, et al.
Breast (Edinburgh, Scotland)|February 3, 2012
A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyAndrew Fong, Jesmin Shafiq, Christobel Saunders, et al.
Breast Cancer Research and Treatment|June 10, 2011
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trialSirwan Hadad, Takayuki Iwamoto, Lee Jordan, et al.
Pageof 2